Researcher.Life Logo

Rheumatology and Therapy : Impact Factor & More

eISSN: 2198-6584pISSN: 2198-6576
JournalOpen Access

Key Metrics

CiteScore
4.1
H-Index
29
Impact Factor
< 5
SJR
Q1Rheumatology
SNIP
1.31
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Rheumatology and Therapy

Rheumatology and Therapy Journal Specifications

Overview
Publisher SPRINGER
Language English
Frequency Quarterly
Article Processing ChargesEUR 5500 | USD 6850 | GBP 4700
Publication Time6
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyQuarterly
Publication Start Year2014
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 6
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY-NC
OA statementVisit website
View less

Planning to publish in Rheumatology and Therapy ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Rheumatology and Therapy

Cutaneous Manifestations in Psoriatic Arthritis: Phenotypes, Clinical Burden, and Therapeutic Implications.
  • 18 May 2026
  • Rheumatology and therapy
Olokizumab Improves Patient-Reported Outcomes in Patients with Active Rheumatoid Arthritis up to 106Weeks (Results from the Open-Label Extension of Phase III Randomized Clinical Trials).
  • 16 May 2026
  • Rheumatology and therapy
Hydroxychloroquine as an Adjunct Therapy for Secondary Thrombosis Prevention in Primary Antiphospholipid Syndrome: A Systematic Review and Meta-analysis.
  • 9 May 2026
  • Rheumatology and therapy
Golimumab for the Treatment of Rheumatoid Arthritis: A Narrative Review of Pivotal Randomized Trials and Real-World Studies.
  • 5 May 2026
  • Rheumatology and therapy
Prospective Quantification of Glucocorticoid Toxicity Across Dosage Ranges in Systemic Lupus Erythematosus: Insights from the Glucocorticoid Toxicity Index.
  • 28 Apr 2026
  • Rheumatology and therapy
Pharmacokinetics of Certolizumab Pegol in Pregnancy: Results from the Open-Label CHERISH Study.
  • 21 Apr 2026
  • Rheumatology and therapy
Cutaneous Manifestations in Psoriatic Arthritis: Phenotypes, Clinical Burden, and Therapeutic Implications.
  • 18 May 2026
  • Rheumatology and therapy
Olokizumab Improves Patient-Reported Outcomes in Patients with Active Rheumatoid Arthritis up to 106Weeks (Results from the Open-Label Extension of Phase III Randomized Clinical Trials).
  • 16 May 2026
  • Rheumatology and therapy
Hydroxychloroquine as an Adjunct Therapy for Secondary Thrombosis Prevention in Primary Antiphospholipid Syndrome: A Systematic Review and Meta-analysis.
  • 9 May 2026
  • Rheumatology and therapy
Golimumab for the Treatment of Rheumatoid Arthritis: A Narrative Review of Pivotal Randomized Trials and Real-World Studies.
  • 5 May 2026
  • Rheumatology and therapy
Prospective Quantification of Glucocorticoid Toxicity Across Dosage Ranges in Systemic Lupus Erythematosus: Insights from the Glucocorticoid Toxicity Index.
  • 28 Apr 2026
  • Rheumatology and therapy
Pharmacokinetics of Certolizumab Pegol in Pregnancy: Results from the Open-Label CHERISH Study.
  • 21 Apr 2026
  • Rheumatology and therapy

FAQs on Rheumatology and Therapy